MRK

Merck News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -0.06% 76.88 19:58:01
Open Price Low Price High Price Close Price Prev Close
77.12 76.77 77.76 76.87 76.93
more quote information »

Recent News

Date Time Source Heading
7/29/202112:30BWMerck Announces Appointment of Cristal N. Downing as Chief..
7/29/202107:26SEEKMerck narrows 2021 revenue guidance; records $600M benefit..
7/29/202107:01EDGARCurrent Report Filing (8-k)
7/29/202106:31SEEKMerck EPS misses by $0.04, beats on revenue
7/29/202106:30BWMerck Announces Second-Quarter 2021 Financial Results
7/28/202108:00SEEKDosing underway in ALX Oncology/Merck's mid-stage ASPEN-04..
7/27/202113:34BWMerck Announces Fourth-Quarter 2021 Dividend
7/27/202107:53SEEKMerck's late-stage KEYNOTE-355 trial met endpoint of overall..
7/27/202107:51DJNMerck's Keytruda Hits Key Endpoint in Metastatic..
7/27/202107:00DJNMerck Gets FDA Expanded OK for Keytruda in Breast Cancer
7/27/202106:48SEEKFDA OKs Merck's Keytruda/Chemotherapy combo in..
7/27/202106:45BWMerck Announces Phase 3 KEYNOTE-355 Trial Met Primary..
7/27/202106:30BWFDA Approves KEYTRUDA® (pembrolizumab) for Treatment of..
7/22/202106:45BWFDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA®..
7/21/202108:15DJNMerck Says Verquvo Granted Marketing Authorization in..
7/21/202107:14BWVERQUVO® (vericiguat) Approved in the European Union
7/20/202106:48DJNMerck Posts Positive Safety Data for Investigational HIV..
7/20/202106:08SEEKMerck presents new data from mid-stage oral islatravir study..
7/20/202106:00BWMerck Presents New Data from Ongoing Phase 2a Clinical Trial..
7/19/202113:59DJNLigand Pharmaceuticals Shares Rise 7% After FDA Approves..
7/16/202117:15BWMerck Announces U.S. FDA Approval of VAXNEUVANCE™..
7/15/202114:24DJNMerck Says Data Positive From Keytruda Breast Cancer Study
7/15/202113:30BWKEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery &..
7/12/202106:55BWMerck Announces Presentation of New Data from Broad HIV..
7/12/202106:45BWInterim Results from Phase 2/3 Studies of Molnupiravir, an..
7/09/202108:18SEEKGalectin Therapeutics shares soar on early-stage Belapectin..
7/09/202105:41SEEKIndia's Hetero seeks emergency use authorization for Merck's..
7/07/202112:50DJNOncoSec Medical Shares Rise 25% on Keytruda Deal With Merck
7/07/202106:38DJNOncoSec Medical, Merck To Collaborate On Melanoma Treatment..
7/06/202116:13SEEKOncoSec surges 20% after teaming up with Merck for..
7/06/202107:30DJNMerck's Keytruda Expanded Label Approved by FDA
7/06/202107:06SEEKFDA approves expanded indication for Merck’s Keytruda in..
7/06/202106:45BWFDA Approves Expanded Indication for Merck’s KEYTRUDA®..
7/02/202109:40EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202109:39EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202109:37EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202109:35EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202116:05BWMerck Provides Update on KEYTRUDA® (pembrolizumab)..
7/01/202107:41SEEKNGM Bio amends collaboration with Merck to advance medicines..
6/30/202116:00BWMerck to Hold Second-Quarter 2021 Sales and Earnings..
6/30/202109:40DJNSellas Life Sciences Reports on Ovarian Cancer Treatment,..
6/30/202108:42DJNAlpine Immune Sciences in Collaboration With Merck for..
6/30/202108:07SEEKAlpine Immune shares rise on clinical trial collaboration..
6/29/202109:05PRNUSMerck Animal Health Survey Reveals Pet Owners Need Advice..
6/29/202108:30PRNUSOneTen Launches Technology Platform to Create and Enable One..
6/29/202107:28DJNMerck Gets European Commission's Approval for Keytruda in..
6/29/202107:12SEEKMerck's Keytruda + chemo combo OK'd in Europe for..
6/29/202106:45BWEuropean Commission Approves Merck’s KEYTRUDA®..
6/25/202115:58SEEKOrganon, Microspherix make headway on Nexplanon patents..
6/24/202111:39DJNMerck Names Michael Klobuchar Chief Strategy Officer
See more news about this stock »
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210801 02:35:36